Gilliland Jeter Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
26,838
-10,916
-29% -$593K 0.3% 70
2026
Q1
$2.37M Hold
37,754
0.7% 40
2025
Q4
$3.6M Sell
37,754
-1,083
-3% -$106K 1.09% 24
2025
Q3
$3.79M Sell
38,837
-473
-1% -$49K 1.17% 19
2025
Q2
$4.22M Sell
39,310
-171
-0.4% -$17.3K 1.37% 14
2025
Q1
$3.98M Sell
39,481
-1,095
-3% -$110K 1.41% 15
2024
Q4
$3.62M Sell
40,576
-921
-2% -$81.1K 1.22% 19
2024
Q3
$3.48M Sell
41,497
-70
-0.2% -$5.52K 1.12% 22
2024
Q2
$3.2M Sell
41,567
-652
-2% -$47.7K 1.08% 21
2024
Q1
$2.89M Buy
42,219
+2,838
+7% +$182K 1.01% 23
2023
Q4
$2.28M Buy
+39,381
New +$2.1M 0.94% 31

Other funds holding BSX

Gilliland Jeter Wealth Management's BSX Position: Q2 2026 in Review

Gilliland Jeter Wealth Management reduced its Boston Scientific (BSX) stake by 29% in Q2 2026, selling an estimated $593K and leaving 26,838 shares worth $1.15M. The position accounts for 0.3% of the portfolio, ranked #70.

Gilliland Jeter Wealth Management first reported a position in BSX in Q4 2023 and has held it in 11 quarters since. The position peaked at $4.22M in Q2 2025. 764 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Gilliland Jeter Wealth Management held 26,838 shares of Boston Scientific worth $1.15M as of Q2 2026.
  • Gilliland Jeter Wealth Management sold 10,916 Boston Scientific shares in Q2 2026, an estimated $593K.
  • Boston Scientific made up 0.3% of Gilliland Jeter Wealth Management's portfolio in Q2 2026, its #70 holding.
  • Gilliland Jeter Wealth Management first reported a position in Boston Scientific in Q4 2023 and has held it in 11 quarters since.
  • Gilliland Jeter Wealth Management's Boston Scientific position peaked at $4.22M in Q2 2025.
  • 764 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Gilliland Jeter Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.